TapestryHealth Announces Appointment of Bill Golden and Isaac Ullatil to Board of Directors
STRATFORD, Conn., Sept. 30, 2024 /PRNewswire/ -- TapestryHealth, a leading provider of innovative healthcare solutions, is pleased to announce the...
News
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application REHOVOT, Israel, Sept....
TE Connectivity completes change in place of incorporation to Ireland
GALWAY, Ireland, Sept. 30, 2024 /PRNewswire/ -- TE Connectivity plc (NYSE: TEL) today completed the change in the place of...
COVID’s ‘Hidden Figure’ Addresses ‘Techanthropy’ and Small Business Challenges in New Product and National Column
BALTIMORE, MD / ACCESSWIRE / September 30, 2024 / Tiffany Tate, CEO of VAULT Technologies and a recognized leader in...
Revolutionizing Med Spa Excellence: Academy of Aesthetics Offers Top-Tier Medical Director Services and Private Training for Injectors
Academy of Aesthetics, led by Megan Davies FNP-BC, CANS, announces the launch of its Medical Director services and Private Training...
Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production
First Generation ‘MicroPearls Pro™'and "MicroPearls ProX™" Will Support Largest Mushroom Ingredient CategoriesLAS VEGAS, NV / ACCESSWIRE / September 30, 2024...
2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy
ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry...
2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy
ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation's leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry...
NervGen Pharma Provides Update on Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
Target enrollment in the chronic cohort close to completionVancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - NervGen Pharma Corp....
Study Indicates Significant Radiation Reduction for Breast Cancer Patients
Lumpectomy Patients Received VeraForm® Marker and APBI Therapy for Breast Cancer TreatmentSAN FRANCISCO, CA / ACCESSWIRE / September 30, 2024...
Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care
Top Startup Award Marks a Year of Milestones for Colorado's Leading Mental Health InnovatorWESTMINSTER, CO / ACCESSWIRE / September 30,...
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an...
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the...
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial – Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID
SHELTON, CT / ACCESSWIRE / September 30, 2024 / NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), reports that it has...
Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
CEO Corner segments to include additional discussion related to press releases, events, corporate updates and pipeline progress Provides interested parties...
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
Academic group to receive a total of $22 million for the trialLA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) --...
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on...
New 3-Year Skeletal Dynamics Data for Adults with Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide) Presented at ASBMR 2024
COPENHAGEN, Denmark, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) shared 3-year results from the Company’s ongoing...
Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...